CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
4.36 / 10
Netural
Technically, CTOR scores 4.36/10 with neutral bias. Candlestick patterns show a mix of signals: Long Upper Shadow and Long Lower Shadow are bearish, but Marubozu White is bullish. Recent indicator trends are volatile, with no clear directional dominance, reinforcing a neutral stance.
Analysis Checks(1/3)
Long Upper Shadow
Score3.14/10
Win Rate44.44%
Hist. Signals108
Avg Return1.94%
Score3.14/10
Win Rate44.44%
Hist. Signals108
Avg Return1.94%
Marubozu White
Score6.43/10
Win Rate55.56%
Hist. Signals18
Avg Return3.04%
Score6.43/10
Win Rate55.56%
Hist. Signals18
Avg Return3.04%
Long Lower Shadow
Score3.5/10
Win Rate46.67%
Hist. Signals105
Avg Return2.21%
Score3.5/10
Win Rate46.67%
Hist. Signals105
Avg Return2.21%
Long Upper Shadow
Score3.14/10
Win Rate44.44%
Hist. Signals108
Avg Return1.94%
Score3.14/10
Win Rate44.44%
Hist. Signals108
Avg Return1.94%
Long Lower Shadow
Score3.5/10
Win Rate46.67%
Hist. Signals105
Avg Return2.21%
Score3.5/10
Win Rate46.67%
Hist. Signals105
Avg Return2.21%
Marubozu White
Score6.43/10
Win Rate55.56%
Hist. Signals18
Avg Return3.04%
Score6.43/10
Win Rate55.56%
Hist. Signals18
Avg Return3.04%
Technical Analysis of CTOR?
- CTOR presents a Netural setup with a Technical Score of 4.36/10. Key technical indicators highlight an RSI of 51.07 and a MACD of 0.02, with the trend anchored by the 50-Day SMA at 1.14. Traders should monitor key support at 1.07 and resistance at 1.15.
